# Study That Evaluates the Effect of CYP3A4 Inhibition on Lu AG06466 in Healthy Men and Women

> **NCT04405323** · PHASE1 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Lu AG06466
- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT04405323
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-20
- **Primary completion:** 2020-07-28
- **Final completion:** 2020-07-28
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04405323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04405323, "Study That Evaluates the Effect of CYP3A4 Inhibition on Lu AG06466 in Healthy Men and Women". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04405323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*